The video opens on a bathroom mirror and a glass of water turning the colour of a swimming pool. A woman squeezes in a few drops, drinks, and sticks out a tongue as blue as a gel pen. The caption promises focus and "mitochondria", and the comments ask the same thing over and over: where do you buy it?

At 7:30 a.m. you pause the video with your thumb. In your other hand is the small white pill you have taken every morning for years, and the caption says nothing about it.

What follows is the sequence the medical literature describes when those two meet. It will not happen to everyone, and it does not need to happen to you. Methylene blue is a potent MAO-A inhibitor. Taken with many antidepressants, it can trigger serotonin syndrome, and Health Canada and the US FDA both warned about it in 2011.

Glass of water turning bright blue from methylene blue drops beside a hand holding an SSRI-style white pill

The short answer: Methylene blue and SSRIs should not be combined without your prescriber, because the mix can cause serotonin syndrome. Methylene blue is a potent MAO-A inhibitor, so it stops the body breaking down the extra serotonin an SSRI keeps in circulation. Health Canada and the US FDA both warned about the combination in 2011.

  • Health Canada warned about methylene blue with serotonin reuptake inhibitors in February 2011, five months before the FDA
  • Mayo Clinic says serotonin syndrome usually begins within several hours of starting a new drug or a higher dose
  • Statistics Canada found 14% of Canadian women had taken a medication for a mood disorder in the past month
In your cabinet Generic names to look for Risk with methylene blue What to do
SSRI and SNRI antidepressants fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine, venlafaxine, desvenlafaxine, duloxetine High; named in the FDA warning Do not combine. Keep taking your prescription and ask your prescriber.
Older antidepressants clomipramine, imipramine, amitriptyline; MAOIs such as phenelzine and tranylcypromine High for clomipramine and imipramine; the FDA also lists amitriptyline and MAOIs Do not combine.
Pain and cough medicines tramadol, meperidine, dextromethorphan (the "DM" in cough syrups), chlorpheniramine Flagged by pharmacologists as serotonin reuptake blockers Check every cold remedy with a pharmacist.
Mood supplements St John's wort, 5-HTP, L-tryptophan Serotonergic, with known antidepressant interactions Do not stack them with methylene blue.

7:45 a.m.: the dye with a family tree

The drops go in and the water turns that swimming-pool blue. That colour is a clue to the history. Heinrich Caro, a German chemist trained as a textile colourist, made methylene blue in 1876 to dye cotton. Within a few years a young doctor named Paul Ehrlich was using it against malaria, the first time an infectious disease was cured with a synthetic substance.

Bolts of cotton dyed deep methylene blue hanging to dry inside a 19th-century textile works

Then the family tree gets stranger. Chemists later built on methylene blue's structure on the way to chlorpromazine, and variations on that molecule produced imipramine, the first tricyclic antidepressant. The dye in the glass is a distant ancestor of the pills it now clashes with.

In 2007, pharmacologists at the University of St Andrews tested methylene blue against purified human monoamine oxidase, the enzyme that clears serotonin. It turned out to be a potent, tight-binding inhibitor of the A form, the same action as the old MAOI antidepressants. Your morning pill keeps more serotonin in circulation, and the blue drops stop your body from breaking it down.

Mid-morning: what are the first signs of serotonin syndrome?

Mayo Clinic says the reaction usually begins within several hours of a new drug or a higher dose. Early signs include restlessness, confusion, a racing heart, heavy sweating, shivering, goosebumps, twitching muscles and diarrhea.

Woman at a kitchen counter with a hand on her forehead beside a glass of water tinted with methylene blue

Several of those could pass for a third espresso or a bad night, which is exactly why the timing matters. If they arrive on the morning you first tried the drops, the drops are the prime suspect.

Most documented cases involved hospital doses given into a vein. That reassures less than it sounds. Anesthesia safety specialists note that even doses below the usual hospital range are likely to block the enzyme meaningfully. Nobody has established a safe lower dose for combining methylene blue and SSRIs. The label on a dropper bottle cannot tell you how much is too much with your prescription, because nobody knows.

Afternoon: when do methylene blue and SSRIs become an emergency?

Severe serotonin syndrome brings high fever, seizures, an irregular heartbeat and loss of consciousness, and it can be fatal. If you have mixed methylene blue with anything in the table and feel unwell, call 911 or go to an emergency department. Bring both bottles.

ISMP Canada, the national medication-safety group, has described one such case. A patient on paroxetine was given methylene blue during a hospital procedure and ended up in intensive care on a breathing tube. Canada had already warned about exactly this pairing in February 2011, five months before the FDA did.

A second, rarer warning sits in the fine print. Québec's poison and antidote centre notes that in people with G6PD deficiency, a common inherited enzyme condition, methylene blue can break down red blood cells. A home dropper has no way of checking for either risk, so the checking has to happen before the first drop.

The next morning: if what you wanted was focus

None of this is a niche worry. Statistics Canada found that 14% of Canadian women had taken a medication for a mood disorder in the past month, twice the rate in men. The woman most tempted by a focus drop is often the woman already managing her mood.

Pharmacist at a pharmacy counter reviewing a prescription bottle with a woman customer

Brain fog on an antidepressant is a common, reasonable thing to raise with whoever prescribed it. No supplement replaces an antidepressant, and nothing below is a way to taper off one. What follows are small, non-serotonergic rituals for a clearer afternoon.

Amoda Ceremonial Matcha tin, 30 grams

AMODA Ceremonial Matcha (30 g), $30.49

If the ritual you loved was the colourful glass, make it green. This stone-ground organic matcha whisks smooth with nothing but hot water and brings the gentle lift of green tea to your mid-morning.

Shop now

Fatigue can also be a deficiency in disguise, and bloodwork is the way to find out.

Genestra Active B Complex bottle, 60 vegetarian capsules

GENESTRA Active B Complex (60 veg caps), $41.75

One capsule covers the whole B family in active forms such as methylcobalamin and methylfolate. If your blood test shows you running low, it fits beside the morning pill without competing with it.

Shop now

A blue tongue fades by dinner. Before you order the drops, read the generic name on your prescription bottle aloud to a pharmacist, along with anything from the cold-and-flu shelf. It takes a minute, and it keeps the rest of this timeline hypothetical.

This article is general information and does not replace advice from your doctor or pharmacist.

Shop the story

Frequently asked questions

Can I pause my antidepressant for a few days and try methylene blue?

No. When a hospital must plan methylene blue for someone on these drugs, the FDA advises stopping most serotonergic antidepressants at least two weeks beforehand, and fluoxetine at least five weeks. Stopping on your own carries its own risks, so that decision belongs with your prescriber.

Are any antidepressants safer with methylene blue?

Psychiatrist and pharmacologist Ken Gillman argues that mirtazapine, bupropion and tricyclics other than clomipramine and imipramine are not implicated in serious toxicity. The FDA's list is broader. Because the experts draw the line differently, your pharmacist should judge your exact prescription.

Does methylene blue actually improve focus?

The human evidence is thin. In a 2025 National Geographic report, Temple University physician Roger Rothenberg described the focus claims as based entirely in theory, from tissue cultures and rats. In the US, its FDA approval is for methemoglobinemia, a blood disorder treated in hospital.

Read next

Sources